Cabio & New Nutrition Grandly Release the 2025 "Trend Insight Report on Syntheti

Cabio, in collaboration with New Nutrition, grandly released the "Trend Insight Report on Synthetic Biology and Nutritional Health". From the perspective of the entire industrial chain, the report reveals how synthetic biology technology moves from the laboratory to the dining table and transforms concepts into nutritional and health products. This trend insight report is not only an industry reference but also a "key" to unlocking the future nutritional and health industry—it outlines the blueprint of a trillion-yuan market with data, interprets how technology reconstructs industrial logic through cases, and even answers a core question from a forward-looking perspective: When "creating substances" becomes possible, what kind of paradigm shift will the human nutritional and health industry usher in?

As an emerging discipline, synthetic biology focuses on studying how organisms can mass-produce specific products and has been widely applied in various fields such as biomedicine, energy and chemical engineering, food and beverages. The 2025 "Trend Insight Report on Synthetic Biology and Nutritional Health" not only conducts an in-depth analysis of the current development status of the synthetic biology and nutritional health field but also provides accurate predictions and forward-looking guidance for future trends. It will offer valuable information and profound insights to industry practitioners, researchers, investors, and the general public, helping them seize opportunities in the field of synthetic biology and nutritional health—where opportunities and challenges coexist—and work together to create a better future.

Meanwhile, driven by both breakthroughs in biotechnology and the upgrading of consumer demand, the 2025 "Trend Insight Report on Synthetic Biology and Nutritional Health" takes Cabio as a case study. With several of its popular application products as examples, the report conducts a detailed analysis of the raw material development, market scale, regulations, and implementation cases of human milk oligosaccharides (HMOs), ergothioneine, ectoine, astaxanthin, N-acetylneuraminic acid (sialic acid), algal oil DHA, and rare sugars. It intuitively demonstrates the impact of synthetic biology on the food industry, realizing the leap from "scarcity" to "affordability for all". This trend report will guide us to gain insight into how synthetic biology, in the role of a "creator", reshapes the underlying logic of the nutritional and health industry.

How Does Synthetic Biology Transform the Food Industry?

Synthetic biology is applied in the food industry to achieve green development:

• Develop biosynthetic pathways to improve current food production processes and enhance food traceability.
• Produce new types of food while improving their safety and quality.
• Use host bioengineering to produce desired food types/ingredients and agricultural metabolites.

Products/Fields Affected:

• Substitutes for traditional products: Artificial pigments, sweeteners, artificial starch
• Functional foods and nutrients: Sweeteners, spices
• Other fields: Dairy products, meat products, packaging materials (degradable packaging), green fibers, green food

As one of the earliest enterprises in China engaged in bio-fermentation research and synthetic biology industrial transformation, Cabio is committed to providing high-quality nutrient products and innovative solutions for global customers in the nutrition and health field through sustainable bio-manufacturing methods. Since its listing in 2019, Cabio has gradually developed from a traditional bio-manufacturing factory into an intelligent manufacturing enterprise. It is not only one of the important global suppliers of ARA and DHA raw materials but also has realized the mass production of HMOs and BC through synthetic biology technology.

Relying on three major production bases and a R&D center—the Wuhan Synthetic Biology Innovation Center—Cabio has established a full technology chain for bio-manufacturing and built a global R&D innovation and technology sharing platform for synthetic biology. It provides raw materials and innovative solutions for more than 500 customers in the global market, including Danone, Nestlé, Yili, Feihe, and Cargill.

For years, Cabio has focused on synthetic biology technology, integrated cutting-edge technologies such as bioinformatics, biocomputing, and artificial intelligence, and based on the underlying technology of synthetic biology, built a full-chain synthetic biology technology platform covering high-value molecule mining, directed cell construction and optimization, and cell verification of product efficacy. Utilizing a multi-scenario application ecosystem with synthetic biology as the technical base, Cabio continuously incubates and matures biotechnology and products, builds a complete technology chain from strain construction to technical services and efficacy application research, and actively provides innovative development ideas and scientific application solutions for enterprises in the global nutritional health field, pharmaceutical industry, and cosmetics industry.

With its incubation capability across the full technology chain, Cabio is committed to building a national-level incubator for synthetic biology, deeply implanting the technical "genes" of synthetic biology into the development of the enterprise. At present, Cabio has successfully realized the industrial application of a number of core technologies and built eight core technology platforms covering all links from basic research to application development, demonstrating strong innovation capabilities and industrial transformation capabilities. In terms of industrial chain integration, Cabio actively promotes the in-depth integration of synthetic biology with the nutritional health, food, pharmaceutical, and other industries, and builds an organically developing industrial ecosystem.

In 2025, Cabio joined hands with OE Biotech to introduce multi-omics technology, optimize key processes, and greatly improve the efficiency and accuracy of raw material research. While actively advancing the implementation and transformation of the Wuhan Synthetic Biology Innovation Center project, Cabio has built a R&D ecosystem and participated in the formulation of standards to jointly promote the development and growth of the synthetic biology industry, setting a model for the collaborative innovation and sustainable development of the industry.

The "Trend Insight Report on Synthetic Biology and Nutritional Health" was officially released at the 2025 New Nutrition Conference, and simultaneously launched on the "Jinghe Island" WeChat Mini Program and Cabio's official WeChat account. Let us jointly look forward to synthetic biology creating more miracles in the field of nutritional health and reshaping the future of nutritional science.

If you wish to settle in the Synthetic Biology Innovation Center, please send an email to info@cabio.cn to get more information.